Personalized Medicine: Oncogenetics

I’m back again to keep you up-to-date in this emerging field of medicine. I thought I should dedicate a whole blog carnival to this topic, but I still don’t have enough time for this. So here is a selection of blogposts about individualized medicine. Oncogenetics has already been centralised around personalization, but according to these articles, plenty of improvements are going to be introduced in the near future:

For many people in medicine, the Holy Grail is the card or chip carried by a patient with the person’s genetic code. That code would tell them what drugs and other treatments would work best for a specific illness. This vision is driving long-term plans for many companies and, unfortunately, these companies are beginning to ask investors for money.


Another little-known company, this time English, has thrown its hat into the Archon X-Prize ring… $500/genome in hours is the target throughput (no mention of error bars on those estimates!)

GenoTrim tests five genes that influence weight…

In Wednesday’s New York Times, Gina Kolata reports on the Veteran Administration’s new national directive which requires states to agree to conditions prior to acquiring cancer patients’ personal information and health records.

Follow Scienceroll for more about personalized medicine!